{"id":793,"date":"2016-11-01T11:39:01","date_gmt":"2016-11-01T11:39:01","guid":{"rendered":"https:\/\/abolongroup.com\/?post_type=abolon-transactions&#038;p=793"},"modified":"2024-08-07T11:39:36","modified_gmt":"2024-08-07T11:39:36","slug":"ik-investment-partners-to-acquire-zytoservice","status":"publish","type":"abolon-transactions","link":"https:\/\/abolongroup.com\/de\/abolon-transactions\/ik-investment-partners-to-acquire-zytoservice\/","title":{"rendered":"IK Investment Partners to acquire ZytoService"},"content":{"rendered":"<p>In November 2016, IK Investment Partners, a European private equity firm, acquired ZytoService Group, a leading compounder of pharmaceuticals for patient-individualised infusions, from the founders and Capiton. ZytoService is, through the acquisition and greenfield opening of outpatient oncology practices, also the largest focused oncology practice group in the DACH region.<\/p>\n<p>The parties have agreed not to disclose the financial terms of the transaction.<\/p>\n<p>Abolon acted as exclusive commercial due diligence advisor to IK Investment Partners.<\/p>\n","protected":false},"template":"","class_list":["post-793","abolon-transactions","type-abolon-transactions","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/abolongroup.com\/de\/wp-json\/wp\/v2\/abolon-transactions\/793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/abolongroup.com\/de\/wp-json\/wp\/v2\/abolon-transactions"}],"about":[{"href":"https:\/\/abolongroup.com\/de\/wp-json\/wp\/v2\/types\/abolon-transactions"}],"wp:attachment":[{"href":"https:\/\/abolongroup.com\/de\/wp-json\/wp\/v2\/media?parent=793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}